PATENT CLAIM ANALYSIS

Application Number: 16186018
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["546", "210000"]

Abstract:
Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.

Claim (Index 1):
A compound comprising the structure of: wherein R 1 , R 2-5 , R 6 , R 7 , and X, are selected from any combination of the suitable substituents and moieties described and/or depicted herein; or a salt thereof.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 98.0
- Lexical Diversity: 1.29032
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15509989', '16073673', '14003547', '13362242', '14416051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7551766669009135
- 35 USC 102 Novelty (BERT): 0.4969200071865221
- Combined Prediction Score: 0.7293510009294744
- Mean Citation Score: 228.476812
- Max Citation Score: 240.59995
- Similarity Product: 166.2896682396412

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test